drugset / Trial / NCT06715592
ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study
Phase 2
Active not recruiting
18 enrolled
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NaSingle-groupOpen-labelTreatment
Summary
Patients with a new diagnosis or recurrence of high-grade squamous precancerous lesions or initially non-invasive vulvar Paget's disease, who have not undergone other types of treatment, will be considered at the Fondazione Policlinico Universitario A. Gemelli - IRCCS - in Rome.
Timeline
- Start
- 2023-05-23
- Primary completion
- 2025-03-31
- Completion
- 2027-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bleomycin | Unknown | — | Other |
| Subject | Cisplatin | Other / unclassified | — | Other |